author-photo

Tadashi Nakanishi

Eisai

7

Papers

40

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan

2021 Cancer Science
Show All
- Source
- Cite
- Save
Citations (1)
Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B-cell lymphoma.

2021 Cancer Science
Show All
- Source
- Cite
- Save
Citations (3)
Abstract CT176: Phase 2 study of tazemetostat in Japanese patients with relapsed or refractory EZH2 mutation-positive B-cell Non-Hodgkin's Lymphoma

2021 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
Phase 2 study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma.

2021 Cancer Science
Show All
- Source
- Cite
- Save
Citations (1)